跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Leukast - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Leukast
Approved
STANDARD
Leukast
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bf827767e59718d3
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
bf827767e59718d3
Drug Approval Philippines Name
Leukast
Product Name
Leukast
Registration Number
DR-XY36106
Brand Name
Leukast
Generic Name
Montelukast (as sodium)
Dosage Form
Chewable Tablet
Dosage Strength
4 mg
Manufacturer
Lloyd Laboratories, Inc.
Trader
GX International, Inc.
Issuance Date
28 May 2024
Expiry Date
30 June 2029
Pharmacologic Category
Leukotriene Receptor Antagonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bf827767e59718d3
Type
Standard
Back to Philippines FDA Approvals